Syncona Limited Directorate Change (6395W)
December 31 2021 - 2:00AM
UK Regulatory
TIDMSYNC
RNS Number : 6395W
Syncona Limited
31 December 2021
Syncona Limited
Directorate Change
31 December 2021
Syncona Ltd, a leading healthcare company focused on founding,
building and funding global leaders in life science, notes that as
previously announced, Nigel Keen and Nicholas Moss step down as
Non-Executive Directors on 31 December 2021.
Virginia Holmes will become Senior Independent Director and Gian
Piero Reverberi will become Chair of the Remuneration Committee, in
each case from 1 January 2022.
[ENDS]
Enquiries
Syncona Ltd
Natalie Garland-Collins / Fergus Witt
Tel: +44 (0) 7714 916615
FTI Consulting
Ben Atwell / Tim Stamper
Tel: +44 (0) 20 3727 1000
Company Secretary
Citco Fund Services (Guernsey) Limited
Company Secretary
Tel: +44 (0) 1481 758228
About Syncona:
Syncona's purpose is to invest to extend and enhance human life.
We do this by founding and building companies to deliver
transformational treatments to patients in areas of high unmet
need.
Our strategy is to found, build and fund companies around
exceptional science to create a diversified portfolio of 15-20
globally leading healthcare businesses for the benefit of all our
stakeholders. We focus on developing treatments for patients by
working in close partnership with world-class academic founders and
management teams. Our balance sheet underpins our strategy enabling
us to take a long-term view as we look to improve the lives of
patients with no or poor treatment options, build sustainable life
science companies and deliver strong risk-adjusted returns to
shareholders.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAFELFSDEFSEEE
(END) Dow Jones Newswires
December 31, 2021 02:00 ET (07:00 GMT)
Syncona (LSE:SYNC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Syncona (LSE:SYNC)
Historical Stock Chart
From Apr 2023 to Apr 2024